Our Services
Medical Information
Helpful Resources
Published on: 9/24/2026
After menopause, falling estrogen levels shift lipid metabolism, typically raising LDL cholesterol, triglycerides, and lipoprotein(a) while lowering protective HDL function. Other contributing factors include increased visceral fat and weight gain, insulin resistance, reduced physical activity, thyroid changes, genetics such as familial hypercholesterolemia, and certain medications. Because these causes often overlap, the reason for high cholesterol in one woman may differ substantially from another, and each cause points to different treatment priorities. There are several important factors to consider, including how timing of menopause and hormone therapy may influence lipid levels, so see below for the complete answer before drawing conclusions.
Since postmenopausal lipid changes often develop quietly and raise cardiovascular risk years before symptoms appear, it is worth taking a few minutes to complete a free, instant, online symptom check to better understand what may be driving your symptoms and which next steps, tests, or specialists make the most sense for you.
Last reviewed for medical accuracy: 09/24/2026
Dyslipidemia—abnormal levels of lipids (fats) in the blood—is a common issue for women after menopause. As estrogen levels decline, shifts in metabolism, body fat distribution and liver function can combine with lifestyle and genetic factors to raise “bad” cholesterol (LDL), triglycerides and lower “good” cholesterol (HDL). Understanding these changes can help you and your doctor develop a plan to keep your heart and blood vessels healthy.
Dyslipidemia refers to one or more of the following:
Left untreated, dyslipidemia increases the risk of atherosclerosis (plaque buildup), heart attack and stroke.
Menopause marks the end of menstrual cycles, usually between ages 45–55. It’s defined by 12 consecutive months without a period. Key hormonal changes include:
Estrogen plays a protective role in lipid metabolism. When its levels fall, the balance of cholesterol and triglyceride production, transport and clearance shifts in ways that tend to raise cardiovascular risk.
Hormonal Effects on the Liver
Changes in Body Composition
Insulin Resistance & Metabolic Syndrome
Genetic and Age-Related Factors
Lifestyle Contributors
Dyslipidemia often has no symptoms. Routine blood tests (fasting lipid panel) remain the best way to detect:
Guidelines recommend screening every 4–6 years for women under 45 and every 1–2 years for those over 45, or sooner if you have diabetes, high blood pressure or a family history of early heart disease.
A combined approach of lifestyle, diet and (if needed) medication can help you achieve and maintain healthy lipid levels.
If lifestyle changes are not enough, your doctor may recommend:
Your doctor will weigh benefits, risks and possible side effects before prescribing.
While dyslipidemia itself is often silent, it contributes to serious conditions:
If you experience any of these, speak to a doctor promptly. For a quick, free, online symptom check, consider doing a doctor-approved Ubie Symptom Checker.
You can use the free, online symptom check, using the doctor approved Ubie Symptom Checker.
Dyslipidemia after menopause stems mainly from estrogen decline, changes in body fat and metabolism, combined with lifestyle and genetic factors. The good news is that you can take control through diet, exercise, regular screening and, if needed, medication.
Always speak to a doctor about any concerns, especially if you have chest pain, difficulty breathing or other serious symptoms. Early detection and management of dyslipidemia go a long way in protecting your heart and overall health.
(References)
* Honigberg MC, Zekavat SM, Aragam K, Finneran P, Klarin D, Bhatt DL, Januzzi JL Jr, Scott NS, Natarajan P. Association of Premature Natural and Surgical Menopause With Incident Cardiovascular Disease. JAMA. 2019 Dec 24;322(24):2411-2421. doi: 10.1001/jama.2019.19191. PMID: 31738818; PMCID: PMC7231649.
* Krakowiak J, Raczkiewicz D, Wdowiak A, Cichońska D, Bojar I. Atherogenic lipid profile and health behaviours in women post-menopause working in agriculture. Ann Agric Environ Med. 2019 Dec 19;26(4):585-591. doi: 10.26444/aaem/105391. Epub 2019 Mar 11. PMID: 31885232.
* Ko SH, Kim HS. Menopause-Associated Lipid Metabolic Disorders and Foods Beneficial for Postmenopausal Women. Nutrients. 2020 Jan 13;12(1). doi: 10.3390/nu12010202. Epub 2020 Jan 13. PMID: 31941004; PMCID: PMC7019719.
* Díez-Villanueva P, García-Guimaraes MM, Macaya F, Masotti M, Nogales JM, Jimenez-Kockar M, Velázquez M, Lozano Í, Moreu J, Avanzas P, Salamanca J, Alfonso F. Spontaneous Coronary Artery Dissection and Menopause. Am J Cardiol. 2021 Jun 1;148:53-59. doi: 10.1016/j.amjcard.2021.02.007. Epub 2021 Feb 20. PMID: 33617813.
* Zhang L, Liu Q, Zeng X, Gao W, Niu Y, Ma X, Xie H, Zhou X, Yu W, Xu G. Association of dyslipidaemia with osteoporosis in postmenopausal women. J Int Med Res. 2021 Mar;49(3):300060521999555. doi: 10.1177/0300060521999555. PMID: 33775162; PMCID: PMC8010835.
* Jeong IS, Yun HS, Kim MS, Hwang YS. [Incidence and Risk Factors of Dyslipidemia after Menopause]. J Korean Acad Nurs. 2022 Apr;52(2):214-227. doi: 10.4040/jkan.21188. PMID: 35575113.
* Xu Z, Gu S, Wu X, Zhou Y, Li H, Tang X. Association of follicle stimulating hormone and serum lipid profiles in postmenopausal women. Medicine (Baltimore). 2022 Sep 30;101(39):e30920. doi: 10.1097/MD.0000000000030920. PMID: 36181065; PMCID: PMC9524973.
* Yigit E, Unsal S. Isoflavones obtained from red clover improve both dyslipidemia and menopausal symptoms in menopausal women: a prospective randomized placebo-controlled trial. Climacteric. 2024 Dec;27(6):548-554. doi: 10.1080/13697137.2024.2393121. Epub 2024 Sep 10. PMID: 39254422.
* Ichikawa T, Okada H, Hamaguchi M, Hara M, Takashima N, Suzuki S, Tanoue S, Kato Y, Nagayoshi M, Tamura T, Fukui M, Matsuo K. Association of sex hormone-binding globulin and dyslipidemia with Japanese postmenopausal women: a cross-sectional study. Lipids Health Dis. 2025 Jun 10;24(1):212. doi: 10.1186/s12944-025-02634-2. Epub 2025 Jun 10. PMID: 40495241; PMCID: PMC12150563.
* Barbagallo F, Cavallaro A, Cannarella R, Crafa A, Condorelli RA, La Vignera S, Cucinella L, Nappi RE, Calogero AE. A preliminary analysis of the relationship between follicle-stimulating hormone and metabolic parameters in postmenopausal women. Gynecol Endocrinol. 2025 Dec 31;41(1):2562195. doi: 10.1080/09513590.2025.2562195. Epub 2025 Sep 24. PMID: 40988559.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.